Aflac (NYSE:AFL) PT Raised to $82.00

Aflac (NYSE:AFL) had its price target raised by research analysts at Wells Fargo & Company from $81.00 to $82.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s target price indicates a potential downside of 4.61% from the company’s previous close.

Several other equities analysts have also commented on AFL. Piper Sandler increased their price target on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Raymond James increased their price objective on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Keefe, Bruyette & Woods increased their price objective on Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a report on Wednesday, April 10th. Finally, Truist Financial increased their price objective on Aflac from $80.00 to $82.00 and gave the company a “hold” rating in a report on Friday, May 3rd. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Aflac has a consensus rating of “Hold” and a consensus price target of $82.38.

Aflac Stock Up 0.7 %

Shares of AFL stock traded up $0.58 during trading hours on Friday, reaching $85.96. 370,778 shares of the stock were exchanged, compared to its average volume of 2,265,432. The business’s fifty day moving average is $83.51 and its two-hundred day moving average is $82.03. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.08 and a quick ratio of 0.08. Aflac has a 12-month low of $64.10 and a 12-month high of $86.26. The firm has a market capitalization of $48.84 billion, a P/E ratio of 9.46, a P/E/G ratio of 2.23 and a beta of 0.91.

Aflac (NYSE:AFL) last released its earnings results on Monday, May 6th. The financial services provider reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.08. The firm had revenue of $5.44 billion for the quarter, compared to analyst estimates of $4.09 billion. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The business’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.55 earnings per share. As a group, research analysts expect that Aflac will post 6.43 EPS for the current fiscal year.

Insider Activity

In other news, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the transaction, the director now owns 86,090 shares in the company, valued at $6,879,451.90. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, Director Masatoshi Koide sold 30,493 shares of Aflac stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the sale, the director now owns 86,090 shares in the company, valued at approximately $6,879,451.90. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The disclosure for this sale can be found here. Insiders sold a total of 47,093 shares of company stock worth $3,816,610 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Institutional Trading of Aflac

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. TIAA Trust National Association acquired a new stake in Aflac in the 3rd quarter worth about $2,113,000. Allspring Global Investments Holdings LLC lifted its stake in shares of Aflac by 236.1% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 141,158 shares of the financial services provider’s stock valued at $10,834,000 after purchasing an additional 99,162 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Aflac by 7.7% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 52,588 shares of the financial services provider’s stock valued at $4,036,000 after purchasing an additional 3,772 shares in the last quarter. First Trust Direct Indexing L.P. lifted its stake in shares of Aflac by 9.7% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 18,445 shares of the financial services provider’s stock valued at $1,416,000 after purchasing an additional 1,636 shares in the last quarter. Finally, Choate Investment Advisors lifted its stake in shares of Aflac by 2.6% in the 3rd quarter. Choate Investment Advisors now owns 39,018 shares of the financial services provider’s stock valued at $2,995,000 after purchasing an additional 993 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.